Nuformix (NFX)

Sector:

Pharma and Biotech

 0.100p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.49
  • 52 Week Low: 0.096
  • Currency: UK Pounds
  • Shares Issued: 2,609.75m
  • Volume: 7,132,476
  • Market Cap: £2.61m
  • RiskGrade: 322

Nuformix Overview

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. We use our expertise in discovering, developing and patenting novel drug forms with improved physical properties, to develop new products in new indications that are differentiated from the original by way of: dosage, delivery route or presentation, thus creating new and attractive commercial opportunities.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE 516.7%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Nuformix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-21 0.20 (1.38) (0.22)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.05 (1.27) (0.19)p n/a n/a n/a n/a 0.0%
30-Sep-23 n/a (0.93) (0.08)p n/a n/a n/a n/a 0.0%
30-Sep-24 n/a (3.65) (0.45)p n/a n/a n/a n/a 0.0%
30-Sep-25 n/a (0.66) (0.04)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Nuformix Company Announcements

NXP002 Development Update 19-Oct-2026 07:00 RNS
Appointment of Chairman 25-Aug-2026 07:00 RNS
NXP002 Development Update 19-Aug-2026 07:00 RNS

Nuformix ShareCast News

Confirmation of US ODD for NXP002 in IPF 10-Mar-2026 ShareCast
Nuformix loss widens as revenue drops 15-Jul-2021 ShareCast
Nuformix seeks chairman as Blackwell quits after... 10-Feb-2021 ShareCast

Latest Nuformix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.100p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.49
52 Week Low 0.096
Volume 7,132,476
Shares Issued 2,609.75m
Market Cap £2.61m
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.16% below the market average53.16% below the market average53.16% below the market average53.16% below the market average53.16% below the market average
31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average
Price Trend
60.80% above the market average60.80% above the market average60.80% above the market average60.80% above the market average60.80% above the market average
76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for 27-Oct-2026

Time Volume / Share Price
14:10 4,500,000 @ 0.11p
13:08 92,386 @ 0.11p
12:31 1,500,000 @ 0.100p
10:31 1,000,000 @ 0.096p
10:13 40,000 @ 0.11p

Top of Page